Articles published by Daiichi Sankyo![]()
Daiichi Sankyo and Merck Enter into Global Development and Commercialization Agreement for MK-6070
August 06, 2024
From Daiichi Sankyo
Via Business Wire
Tickers
MRK
![]()
IDeate-Lung02 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Relapsed Small Cell Lung Cancer
August 01, 2024
From Daiichi Sankyo
Via Business Wire
Tickers
MRK
![]() ![]() ![]() ![]() From Daiichi Sankyo
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|